RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer

Overview of attention for article published in BMC Cancer, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 24 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

URINARY TRACT CANCER TREATMENT GUIDED BY MUTATIONAL LANDSCAPE

Application WO-2023287839-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.